KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial

NCT06752473 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma (NPC)
EBV

Interventions

BIOLOGICAL: KSD-101

Sponsor

Kousai Bio Co., Ltd.